IVF Hartmann (Switzerland) Performance
| VBSN Stock | CHF 148.00 1.00 0.67% |
IVF Hartmann has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning IVF Hartmann are expected to decrease at a much lower rate. During the bear market, IVF Hartmann is likely to outperform the market. IVF Hartmann Holding currently retains a risk of 1.03%. Please check out IVF Hartmann jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to decide if IVF Hartmann will be following its current trending patterns.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in IVF Hartmann Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, IVF Hartmann is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 46.7 M | |
| Total Cashflows From Investing Activities | -6.4 M |
IVF |
IVF Hartmann Relative Risk vs. Return Landscape
If you would invest 14,300 in IVF Hartmann Holding on November 2, 2024 and sell it today you would earn a total of 500.00 from holding IVF Hartmann Holding or generate 3.5% return on investment over 90 days. IVF Hartmann Holding is generating 0.0645% of daily returns and assumes 1.0339% volatility on return distribution over the 90 days horizon. Simply put, 9% of stocks are less volatile than IVF, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
IVF Hartmann Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IVF Hartmann's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IVF Hartmann Holding, and traders can use it to determine the average amount a IVF Hartmann's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0624
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | VBSN | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.03 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average IVF Hartmann is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IVF Hartmann by adding it to a well-diversified portfolio.
IVF Hartmann Fundamentals Growth
IVF Stock prices reflect investors' perceptions of the future prospects and financial health of IVF Hartmann, and IVF Hartmann fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IVF Stock performance.
| Return On Equity | 0.0544 | |||
| Return On Asset | 0.0315 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 247.54 M | |||
| Shares Outstanding | 2.4 M | |||
| Price To Earning | 25.67 X | |||
| Price To Book | 2.01 X | |||
| Price To Sales | 1.85 X | |||
| Revenue | 144.07 M | |||
| EBITDA | 13.27 M | |||
| Cash And Equivalents | 29.35 M | |||
| Cash Per Share | 14.98 X | |||
| Total Debt | 428 K | |||
| Book Value Per Share | 57.29 X | |||
| Cash Flow From Operations | (2.51 M) | |||
| Earnings Per Share | 3.09 X | |||
| Total Asset | 173.19 M | |||
About IVF Hartmann Performance
Evaluating IVF Hartmann's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if IVF Hartmann has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IVF Hartmann has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF HARTMANN operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 323 people.Things to note about IVF Hartmann Holding performance evaluation
Checking the ongoing alerts about IVF Hartmann for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IVF Hartmann Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IVF Hartmann Holding has accumulated about 29.35 M in cash with (2.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.98. | |
| Roughly 72.0% of the company outstanding shares are owned by insiders |
- Analyzing IVF Hartmann's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IVF Hartmann's stock is overvalued or undervalued compared to its peers.
- Examining IVF Hartmann's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IVF Hartmann's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IVF Hartmann's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IVF Hartmann's stock. These opinions can provide insight into IVF Hartmann's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for IVF Stock Analysis
When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.